Preclinical Pharmacokinetics and Pharmacology Study of RC98: A Programmed Cell Death Ligand 1 Monoclonal Antibody in Cynomolgus Monkeys

CONCLUSION: These data indicate that the immune system was clearly activated. In addition, the non-clinical data could provide a basis for its efficacy evaluation in clinical trials.PMID:38623974 | DOI:10.2174/0113816128248929230920071937

Source: Current Pharmaceutical Design - April 16, 2024 Category: Drugs & Pharmacology Authors: Ling Wang Qiaoning Li Chenglian Deng Zhihao Liu Fang Wang Shenjun Li Lihou Dong Jing Jiang Source Type: research